Venous and arterial thrombosis in COVID-19: An updated narrative review

Venous and arterial thrombosis in COVID-19: An updated narrative review

Hospitalized patients with coronavirus disease 2019 (COVID-19), particularly those admitted to the intensive care unit (ICU) are at high risk of morbidity and mortality. Several observational studies have described hemostatic derangements and thrombotic complications in patients with COVID-19. The a...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Zainab Al Duhailib, Simon Oczkowski, Kamil Polok, Jakub Fronczek, Wojciech Szczeklik, Joshua Piticaru, Manoj J. Mammen, Fayez Alshamsi, John Eikelboom, Emilie Belley-Cote, Waleed Alhazzani
Natura:	Articolo
Lingua:	English
Pubblicazione:	Elsevier 2022-06-01
Serie:	Journal of Infection and Public Health
Soggetti:	Anticoagulation COVID-19 Thrombosis Venous thromboembolism prophylaxis Critically ill D-dimer level
Accesso online:	http://www.sciencedirect.com/science/article/pii/S187603412200123X

Documenti analoghi

Risk Factors and Clinical Significance of D-Dimer in the Development of Postoperative Venous Thrombosis in Patients with Lung Tumor
di: Wang P, et al.
Pubblicazione: (2020-06-01)

Increased Prevalence of Elevated D-Dimer Levels in Patients on Direct Oral Anticoagulants: Results of a Large Retrospective Study
di: Sara Reda, et al.
Pubblicazione: (2022-03-01)

Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results
di: Gualtiero Palareti, et al.
Pubblicazione: (2022-03-01)

Optimal duration of anticoagulant therapy in patients with venous thromboembolism
di: Gualtiero Palareti
Pubblicazione: (2018-09-01)

A Systematic Review on the Use of Aspirin in the Prevention of Deep Vein Thrombosis in Major Elective Lower Limb Orthopedic Surgery: An Update from the Past 3 Years
di: Dylan A. Mistry, et al.
Pubblicazione: (2017-10-01)

Thromboembolism in Arthroplasty: Compliance to Prophylaxis
di: Leandra Marla Aires Travassos Viana, et al.
Pubblicazione: (2021-12-01)

Venous thromboembolism in COVID 19 infection: Prevalence and practice of prophylaxis - A narrative
di: U Vasudeva Rao, et al.
Pubblicazione: (2021-01-01)

Venous thromboembolism in critically ill patients with pneumonia in the pre‐COVID‐19 era: Data from a large public database
di: Miguel Pisani, et al.
Pubblicazione: (2022-10-01)

Prevention of venous thromboembolism in cancer patients: current approaches and opportunities for improvement
di: Alpesh N. Amin, et al.
Pubblicazione: (2011-09-01)

Renal Vein Thrombosis in Idiopathic Thrombocytopenic Purpura
di: Subodh Kumar Das, et al.
Pubblicazione: (2020-03-01)

Ibrutinib in patients with atrial fibrillation – the challenge of thromboembolic prophylaxis
di: Ciuculete Denisa-Corina, et al.
Pubblicazione: (2021-09-01)

Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider
di: Daria Solari, et al.
Pubblicazione: (2021-01-01)

Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery
di: Taishi Hata, et al.
Pubblicazione: (2019-09-01)

New knowledge of prophylaxis and treatment about cancer-associated thrombosis
di: DING Yongjie, ZHANG Liu, LI Qingyun
Pubblicazione: (2023-08-01)

Cancer and Thrombosis: New Treatments, New Challenges
di: Anders Erik Astrup Dahm
Pubblicazione: (2021-06-01)

Risk factors for Venous Thromboembolism and clinical outcomes in adults with sickle cell disease
di: Brittany Scarpato, et al.
Pubblicazione: (2022-03-01)

The importance of D-dimer test in the follow up of patients with deep venous thrombosis
di: Meral Ekim, et al.
Pubblicazione: (2018-07-01)

CONTINUOUS THROMBOPROPHYLAXIS DURING SURGICAL TREATMENT OF PATIENT WITH POLYTRAUMA IN A MULTIDISCIPLINARY HOSPITAL (CASE REPORT)
di: I. G. Belenky, et al.
Pubblicazione: (2017-07-01)

Equivalent VTE rates after total joint arthroplasty using thromboprophylaxis with aspirin versus potent anticoagulants: retrospective analysis of 4562 cases across a diverse healthcare system
di: Chelsea Matzko, et al.
Pubblicazione: (2021-12-01)

PULMONARY EMBOLISM IN BREAST CANCER: ETIOLOGY, PATHOPHYSIOLOGY AND TREATMENT APPROACHES
di: I. D. Rozanov, et al.
Pubblicazione: (2017-01-01)

Dual direct oral anticoagulant therapy in challenging thrombosis: a case series
di: Nicholas L.J. Chornenki, et al.
Pubblicazione: (2024-08-01)

Secondary thrombosis prevention practice patterns in pediatrics: Results of an international survey
di: Hope P. Wilson, et al.
Pubblicazione: (2022-03-01)

Consensus document on anticoagulant management of deep vein thrombosis: A review
di: V S Bedi, et al.
Pubblicazione: (2021-01-01)

Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism prophylaxis in patients with gynecologic malignancies: A quality mini-review
di: Peter W. Ketch, et al.
Pubblicazione: (2024-12-01)

ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST
di: Samir Arnaout, et al.
Pubblicazione: (2011-05-01)

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis
di: Hyeon-Jeong Lee, et al.
Pubblicazione: (2023-05-01)

Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
di: Marcello Di Nisio, et al.
Pubblicazione: (2024-05-01)

Deep vein thrombosis - the review
di: Karol Stępniak, et al.
Pubblicazione: (2024-11-01)

Cancer-Associated Thrombosis: A New Light on an Old Story
di: Sidrah Shah, et al.
Pubblicazione: (2021-05-01)

Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on
di: Sven R. Olson, et al.
Pubblicazione: (2019-07-01)

New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis
di: Mehrie H. Patel, et al.
Pubblicazione: (2024-05-01)

Cerebral vein thrombosis as the initial presentation of acute promyelocytic leukemia (APML)
di: Fizza Zulfiqar, et al.
Pubblicazione: (2025-01-01)

Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities Study
di: Fleur H.J. Kaptein, et al.
Pubblicazione: (2024-01-01)

Preoperative prevalence of deep vein thrombosis in patients scheduled to have surgery for degenerative musculoskeletal disorders
di: Keigo Sato, et al.
Pubblicazione: (2021-06-01)

Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
di: Philip L. Mar, MD, PharmD, et al.
Pubblicazione: (2020-03-01)

Five Challenging Cases of Hereditary Antithrombin Deficiency Characterized by Thrombosis or Complicated Pregnancy
di: Roberts JC, et al.
Pubblicazione: (2022-10-01)

Low Prevalence of Thrombosis Prophylaxis Dose Adjustments Highlights Implications for Patient Safety
di: W. Anthony Hawkins, et al.
Pubblicazione: (2021-10-01)

D-dimer: a useful tool in gauging optimal duration of oral anticoagulant therapy?
di: M. Silingardi, et al.
Pubblicazione: (2013-05-01)

An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study
di: Fumihiro Ogawa, et al.
Pubblicazione: (2021-04-01)

Prevalence, Risk Factors of Deep Venous Thrombosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Cross-sectional Study
di: P SPURTHY, et al.
Pubblicazione: (2024-01-01)